Australian healthcare events in Canberra – September 2025
The first week of September was an inspiring and thought-provoking one in Canberra, with our Directors George Papadopoulos and Michael Aristides attending a series of pivotal events shaping the future of Australian healthcare. ➡️ Medicines Australia’s Horizon...
ISPOR Europe 2025 – 14 Abstracts accepted!
We’re thrilled to share that fourteen of our joint abstracts with Skywards Analytics have been accepted for presentation at ISPOR Europe 2025! Our research spans a diverse range of timely topics, and we look forward to contributing fresh insights to this year’s...
Why Horizon Scanning Matters for Australia’s Healthcare Future?
Horizon Scanning and HTA – Past, Present and Future Horizon Scanning is a systematic approach to identifying early signals of emerging health technologies, trends, and disruptions. In healthcare, it plays a vital role in managing risk, supporting early...
Navigating HTA Assessment: A Comparative Analysis of Singapore and Australia
🔍 New Analysis from Lucid Health Consulting & Vista Health How do health technology assessment (HTA) processes differ between Singapore and Australia and what are the strategic implications for those working across both markets? In this piece,...
Lucid Health Consulting Medtech Reimbursement workshop at AusMedtech 2025!
🚨 Just over a week to go until AusBiotech’s AusMedtech 2025 at the ICC Sydney over 6-May, 2025! The AusMedtech Annual Conference is Australia’s premier event for the medical technology industry, bringing together visionary leaders, innovators, and changemakers to...
Lucid Health Consulting – Wrapping Up 2024 and Looking Ahead to 2025
As 2024 comes to a close, here’s a snapshot of what we’ve been up and what’s ahead in 2025 in the pharmaceuticals, biotech products, medical devices, and technologies world. 🌟 2024 Highlights Healthcare Policy Updates 📌 The HTA Review Report was...
Free Webinar: 10th Annual Drugs & Devices Australia Webinar – 2024
📢 Free Webinar: The 10th Annual Drugs & Devices Australia Webinar – 2024 📽 Missed the webinar? You can catch the full webinar replay and access a PDF copy of our Drugs & Devices Australia, Reimbursement Update 2024 slide deck via our VIDEOs page on our...
Lucid Health Consulting Appointed by Tryptamine Therapeutics Ltd for product registration and reimbursement strategy in Australia.
We are pleased to announce that Lucid Health Consulting has been appointed by Tryptamine Therapeutics Limited to manage the registration and develop a comprehensive reimbursement strategy for their innovative treatment, TRP-8803, (IV-infused psilocin), in Australia....
Recent Comments